Acquisition Alignment Elwyn Specialty Care is part of the BioMatrix family and was acquired in 2017, indicating potential cross-sell opportunities with BioMatrix portfolio managers, shared supplier ecosystems, and integrated specialty pharmacy services.

Specialty Pharmacy Focus As a URAC, ACHC and NCPA accredited specialty pharmacy with expertise in injectable therapies and patient education, there are strong opportunities to offer expanded drug therapies, patient support programs, and co pay assistance through payer and manufacturer channels.

Geographic Footprint Located in Garnet Valley, PA with willingness to deliver nationwide (home, workplace, or doctor’s office) and acceptance of multiple Medicaid plans in PA, NJ, NY, and DE, enabling expansion discussions with regional health plans and ACOs.

Patient Support Capabilities In-house medication regimen review, side-effect management, injection training, and manufacturer patient assistance enrollment create upsell potential for comprehensive patient management services and ongoing monitoring programs.

Financial & Growth Signals Current revenue tier ($10M–$25M) suggests room for scale through expanded payer contracts, telepharmacy offerings, and targeted outreach to similar service providers seeking specialty pharmacy partnerships within the BioMatrix network.